TrialWorld journal of urology2024

A 3-arm randomized control trial to compare the efficacy of re-circulant hyperthermic intravesical chemotherapy versus conventional intravesical mitomycin C and BCG therapy for intermediate-risk non-muscle invasive bladder cancer.

Ankit Sachan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.